Literature DB >> 12369776

Parathyroid hormone and periosteal bone expansion.

A Michael Parfitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12369776     DOI： 10.1359/jbmr.2002.17.10.1741

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  29 in total

Review 1.  Bone strength in primary hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 2.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

3.  The association of serum 25-hydroxyvitamin D with indicators of bone quality in men of Caucasian and African ancestry.

Authors:  K E Barbour; J M Zmuda; M J Horwitz; E S Strotmeyer; R Boudreau; R W Evans; K E Ensrud; C L Gordon; M A Petit; A L Patrick; J A Cauley
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

Review 4.  Anabolic therapy for osteoporosis: parathyroid hormone.

Authors:  Felicia Cosman
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

Review 5.  Periosteum: characteristic imaging findings with emphasis on radiologic-pathologic comparisons.

Authors:  Damien Bisseret; Rachid Kaci; Marie-Hélène Lafage-Proust; Marianne Alison; Caroline Parlier-Cuau; Jean-Denis Laredo; Valérie Bousson
Journal:  Skeletal Radiol       Date:  2014-10-01       Impact factor: 2.199

6.  Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis.

Authors:  Fatma Gossiel; Jessica R Scott; Margaret A Paggiosi; Kim E Naylor; Eugene V McCloskey; Nicola F A Peel; Jennifer S Walsh; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

7.  beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.

Authors:  Mary L Bouxsein; Dominique D Pierroz; Vaida Glatt; Deborah S Goddard; Fanny Cavat; Renée Rizzoli; Serge L Ferrari
Journal:  J Bone Miner Res       Date:  2004-12-06       Impact factor: 6.741

8.  Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Authors:  Emily M Stein; Barbara C Silva; Stephanie Boutroy; Bin Zhou; Ji Wang; Julia Udesky; Chiyuan Zhang; Donald J McMahon; Megan Romano; Elzbieta Dworakowski; Aline G Costa; Natalie Cusano; Dinaz Irani; Serge Cremers; Elizabeth Shane; X Edward Guo; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

9.  Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.

Authors:  Yumie Rhee; Eun-Young Lee; Virginia Lezcano; Ana C Ronda; Keith W Condon; Matthew R Allen; Lilian I Plotkin; Teresita Bellido
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

Review 10.  Progress in osteoporosis and fracture prevention: focus on postmenopausal women.

Authors:  Kenneth G Saag; Piet Geusens
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.